SFX by Ex Libris Inc.

Title:	Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
Source:	Journal of Medicinal Chemistry [0022-2623] Barf, Tjeerd yr:2002

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Balani, Suresh K. "Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys." Drug metabolism and disposition 30.10 (2002): 1059-62.
description	2.	Momose, Y. "Novel 5-Substituted 2,4-Thiazolidinedione and 2,4-Oxazolidinedione Derivatives as Insulin Sensitizers with Antidiabetic Activities." Journal of medicinal chemistry 45.7 (2002): 1518-1534.
description	3.	Alberts, P. "Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains." Endocrinology 144.11 (2003): 4755-4762.
description	4.	Feng, C. "Rhodium(III)-Catalyzed Cross-Coupling of Alkenylboronic Acids andN-Pivaloyloxylamides." Organic letters 16.13 (2014): 3444-3447.
description	5.	Lu, P. "Selective inhibition of dog hepatic CYP2B11 and CYP3A12." The journal of pharmacology and experimental therapeutics 313.2 (2005): 518-528.
description	6.	Joniau, S. "Current vaccination strategies for prostate cancer." European urology 61.2 (2012): 290-306.
description	7.	Momose, Y. "Novel 5-substituted-1H-tetrazole derivatives as potent glucose and lipid lowering agents." Chemical & pharmaceutical bulletin 50.1 (2002): 100-111.
description	8.	Schmalhofer, William A. "Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant properties." Biochemistry 41.24 (2002): 7781-94.
description	9.	Fraser, R. "Cortisol effects on body mass, blood pressure, and cholesterol in the general population." Hypertension 33.6 (1999): 1364-8.
description	10.	Chan, C. "Inhibitors of cholesterol biosynthesis. 1. 3,5-Dihydroxy-7-(N-imidazolyl)-6-heptenoates and -heptanoates, a novel series of 3-hydroxy-3-methylglutarate-CoA reductase inhibitors." Journal of medicinal chemistry 36.23 (1993): 3646-373.
description	11.	Nagisa, Y. "Changes in glycated haemoglobin levels in diabetic rats measured with an automatic affinity HPLC." Clinical and experimental pharmacology & physiology 30.10 (2003): 752-8.
description	12.	Shou, -Magang [Author -Reprint-Author] [. "Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes P450." Drug metabolism and disposition 31.9 (2003): 1161-1169.
description	13.	De Vente, W. "Physiological differences between burnout patients and healthy controls: blood pressure, heart rate, and cortisol responses." Occupational and environmental medicine 60.Suppl.1 (2003): 54-61.
description	14.	Li, Z. "Atipamezole is a promising non-discriminative inhibitor against pan-CYP450 including diclofenac 4′-hydroxylation: A comparison with ABT for drug ADME optimization and mechanism study." European journal of pharmaceutical sciences 130 (2019): 156-165.
description	15.	Feng, C. "Rhodium-catalyzed direct ortho C-H olefination of phenol derivatives." Chemical communications (London. 1996) 47.37 (2011): 10458-10460.
description	16.	Guimond, N. "Rhodium(III)-Catalyzed Heterocycle Synthesis Using an Internal Oxidant: Improved Reactivity and Mechanistic Studies." Journal of the American Chemical Society 133.16 (2011): 6449-6457.
description	17.	Sanchez Adams, J. "Dermis isolated adult stem cells for cartilage tissue engineering." Biomaterials 33.1 (2011): 109-19.
description	18.	Yuana, Y. "Pre-analytical and analytical issues in the analysis of blood microparticles." Thrombosis and haemostasis 105.2011 (2010): 105-408.
description	19.	Baratta, M T. "Canine CYP2B11 metabolizes and is inhibited by anesthetic agents often co-administered in dogs." Journal of veterinary pharmacology and therapeutics 33.1 (2010): 50-55.
description	20.	Aboraia, A. "Synthesis and CYP24A1 inhibitory activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides." Bioorganic & medicinal chemistry 18.14 (2010): 4939-4946.